Cycurion, Inc. Offers Insight On Second Quarter 2025 Results And Recent Business Activities
| CYCURION, INC. AND ITS SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Unaudited) | ||||||||
| June 30, 2025 | December 31, 2024 | |||||||
| Assets: | ||||||||
| Cash and cash equivalents | $ | 1,013,836 | $ | 38,742 | ||||
| Restricted cash | - | 2,048 | ||||||
| Accounts receivable, net | 4,118,888 | 10,353,708 | ||||||
| Other receivables | 400,072 | 434,391 | ||||||
| Prepaid expenses and other current assets | 54,259 | 99,463 | ||||||
| Total current assets | 5,587,055 | 10,928,352 | ||||||
| Deposit for acquisition target | - | 2,000,000 | ||||||
| Property and equipment, net | 16,832 | 20,321 | ||||||
| Software development costs | 4,325,981 | 4,151,981 | ||||||
| Intangible assets, net | 7,917 | 25,000 | ||||||
| Security deposits | 10,351 | 10,351 | ||||||
| Goodwill | 20,788,299 | 6,592,304 | ||||||
| Investments held in trust account | - | 1,834,540 | ||||||
| Total non-current assets | 25,149,380 | 14,634,497 | ||||||
| Total Assets | $ | 30,736,435 | $ | 25,562,849 | ||||
| Liabilities, Mezzanine and Stockholders' Equity: | ||||||||
| Bank loan-revolving credit line | $ | 3,236,167 | $ | 3,249,067 | ||||
| Bank loan - current portion | 620,078 | 774,095 | ||||||
| Loans payable - current portion | 885,240 | 408,516 | ||||||
| Factoring liability | 2,309,160 | - | ||||||
| Subordinated convertible promissory notes | - | 3,333,335 | ||||||
| Promissory notes | 2,669,626 | 2,486,989 | ||||||
| Loans payable - related parties | 150,372 | 148,088 | ||||||
| Accounts payable | 5,088,223 | 3,578,374 | ||||||
| Due to related party | 18,000 | - | ||||||
| Accrued liabilities | 3,848,247 | 3,601,242 | ||||||
| Excise tax payable | 1,167,173 | 1,157,161 | ||||||
| Total current liabilities | 19,992,286 | 18,736,867 | ||||||
| Loans payable - non-current portion | 295,296 | 146,798 | ||||||
| Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively) | - | 1,294,117 | ||||||
| Total non-current liabilities | 295,296 | 1,440,915 | ||||||
| Total liabilities | 20,287,582 | 20,177,782 | ||||||
| Commitments and contingencies (Note 20) | ||||||||
| Mezzanine Equity: | ||||||||
| Common stock subject to possible redemption, $0.0001 par value, 0 and 173,879 shares at redemption value of approximately $11.03 per share, respectively | - | 1,917,309 | ||||||
| Stockholders' Equity: | ||||||||
| Preferred stock ($0.0001 par value, 20,000,000 shares authorized) | ||||||||
| Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 106,816 and 0 issued and outstanding, respectively) | 11 | - | ||||||
| Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 3,000 issued and outstanding, respectively) | - | - | ||||||
| Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 4,851 issued and outstanding) | - | - | ||||||
| Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 0 issued and outstanding, respectively) | 15 | - | ||||||
| Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 0 issued and outstanding, respectively) | - | - | ||||||
| Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - | ||||||
| Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 3,318 and 0 issued and outstanding, respectively) | ||||||||
| Common stock ($0.0001 par value, 100,000,000 shares authorized, 40,353,983 and 10,592,607 shares issued and outstanding, respectively) | 4,036 | 1,059 | ||||||
| Additional paid in capital | 32,661,282 | 6,670,060 | ||||||
| Accumulated deficit | (18,650,614 | ) | (3,203,361 | ) | ||||
| Total stockholders' equity attributable to Cycurion | 14,014,730 | 3,467,758 | ||||||
| Equity attributable to noncontrolling interests | (3,565,877 | ) | - | |||||
| Total stockholders' equity | 10,448,853 | 3,467,758 | ||||||
| Total liabilities and stockholders' equity | $ | 30,736,435 | $ | 25,562,849 | ||||
| CYCURION, INC. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) | ||||||||||||||||
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 | |||||||||||||
| Net revenues | $ | 3,887,915 | $ | 5,001,312 | $ | 7,757,965 | $ | 9,244,167 | ||||||||
| Cost of revenues | 3,651,978 | 3,977,150 | 6,844,265 | 7,873,291 | ||||||||||||
| Gross profit | 235,937 | 1,024,162 | 913,700 | 1,370,876 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative expenses | 4,002,014 | 294,790 | 14,777,281 | 673,767 | ||||||||||||
| Operating (loss)/income | (3,766,077 | ) | 729,372 | (13,863,581 | ) | 697,109 | ||||||||||
| Interest income | - | 20,211 | - | 20,211 | ||||||||||||
| Interest expense | (615,392 | ) | (482,355 | ) | (794,283 | ) | (713,830 | ) | ||||||||
| Loss on debt settlement, net | (907,983 | ) | - | (766,330 | ) | - | ||||||||||
| Other (expense)/income | (962 | ) | 38,866 | (114,706 | ) | (9,871 | ) | |||||||||
| Other expense, net | (1,524,337 | ) | (423,278 | ) | (1,675,319 | ) | (703,490 | ) | ||||||||
| (Loss)/income before income taxes | (5,290,414 | ) | 306,094 | (15,538,900 | ) | (6,381 | ) | |||||||||
| Provision for income tax | - | - | - | - | ||||||||||||
| Net (loss)/income | $ | (5,290,414 | ) | $ | 306,094 | $ | (15,538,900 | ) | $ | (6,381 | ) | |||||
| Less: Net loss attributable to non-controlling interest | 101,659 | - | 101,659 | - | ||||||||||||
| Net (loss)/income attributable to Cycurion | $ | (5,188,755 | ) | $ | 306,094 | $ | (15,437,241 | ) | $ | (6,381 | ) | |||||
| Comprehensive (loss)/income | $ | (5,188,755 | ) | $ | 306,094 | $ | (15,437,241 | ) | $ | (6,381 | ) | |||||
| Earnings per share: | ||||||||||||||||
| Basic | $ | (0.15 | ) | $ | 0.02 | $ | (0.58 | ) | $ | 0.02 | ||||||
| Diluted | $ | (0.15 | ) | $ | 0.01 | $ | (0.57 | ) | $ | 0.01 | ||||||
| Weighted average shares outstanding: | ||||||||||||||||
| Basic | 34,791,716 | 14,968,215 | 26,707,978 | 14,968,215 | ||||||||||||
| Diluted | 34,891,716 | 32,383,372 | 26,807,978 | 16,704,748 | ||||||||||||
| CYCURION, INC. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) | ||||||||
| For the Six Months Ended | ||||||||
| June 30, 2025 | June 30, 2024 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (15,538,900 | ) | $ | (6,381 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock based compensation | 10,534,777 | 10,000 | ||||||
| Amortization of debt discount | 213,036 | - | ||||||
| Depreciation of property and equipment | 3,489 | 4,394 | ||||||
| Amortization of software development costs | 17,083 | - | ||||||
| Loss on debt settlement, net | 766,330 | - | ||||||
| Finance expense | 100,000 | - | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable, net and other receivables | (1,478,433 | ) | (1,267,911 | ) | ||||
| Prepaid expenses and other current assets | 45,204 | 16,050 | ||||||
| Accounts payable and accrued liabilities | (965,708 | ) | 393,435 | |||||
| Net cash used in operating activities | (6,303,122 | ) | (850,413 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Cash acquired on acquisition of subsidiary | 34,983 | - | ||||||
| Issuance of promissory notes | - | (354,000 | ) | |||||
| Purchase of plant and equipment | (174,000 | ) | (238,000 | ) | ||||
| Cash withdrawn from Trust Account in connection with redemption | 1,001,216 | - | ||||||
| Release of Trust Account to Company's bank account | 833,324 | - | ||||||
| Net cash provided by/(used in) investing activities | 1,695,523 | (592,000 | ) | |||||
| Cash flows from financing activities: | ||||||||
| Proceeds from exercise of warrants | 3,664,671 | - | ||||||
| Redemption of common stock subject to redemption | (1,001,216 | ) | - | |||||
| Proceeds from private placement | - | 1,000,000 | ||||||
| Proceeds from capital raise | 265,504 | - | ||||||
| Net proceeds from line of credit | (12,900 | ) | 39,181 | |||||
| Repayment of bank borrowings | (155,114 | ) | (6,503 | ) | ||||
| Proceeds from convertible notes payable | 2,376,500 | - | ||||||
| Proceeds from notes payable | 513,200 | - | ||||||
| Repayments of notes payable | (70,000 | ) | - | |||||
| Net cash provided by financing activities | 5,580,645 | 1,032,678 | ||||||
| Net increase/(decrease) in cash and cash equivalents | 973,046 | (409,735 | ) | |||||
| Cash and cash equivalents, beginning of period | 40,790 | 607,869 | ||||||
| Cash and cash equivalents, end of period | $ | 1,013,836 | $ | 198,134 | ||||
| CYCURION, INC. AND ITS SUBSIDIARIES RECONCILIATION OF GAPP TO NON-GAAP MEASURES (Unaudited) | |||||||||||||||
| For the Three Months Ended | For the Six Months Ended | ||||||||||||||
| June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 | ||||||||||||
| Net (loss)/income attributable to Cycurion | $ | (5,188,755 | ) | $ | 306,094 | $ | (15,437,241 | ) | $ | (6,381 | ) | ||||
| Interest income | - | (20,211 | ) | - | (20,211 | ) | |||||||||
| Interest expense | 615,392 | 482,355 | 794,283 | 713,830 | |||||||||||
| Other (expense)/income | 962 | (38,866 | ) | 114,706 | 9,871 | ||||||||||
| Depreciation and amortization | 10,530 | 2,197 | 20,572 | 4,394 | |||||||||||
| EBITDA (Non-GAAP) | (4,561,871 | ) | 731,569 | (14,507,680 | ) | 701,503 | |||||||||
| Loss on debt settlement, net | 907,983 | - | 766,330 | - | |||||||||||
| Transaction related expenses | 1,676,228 | - | 12,114,122 | - | |||||||||||
| Finance expense | - | - | 100,000 | - | |||||||||||
| Stock-based compensation expenses | 1,012,443 | - | 1,012,443 | - | |||||||||||
| Adjusted EBITDA (Non-GAAP) | $ | (965,217 | ) | $ | 731,569 | $ | (514,785 | ) | $ | 701,503 | |||||

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment